Analytical Data
-
Gene name
LDOC1L
- Application
-
Alternative Names
dJ1033E15.2; DKFZp761O17121; LDOC1L; LDOCL_HUMAN; Leucine zipper down regulated in cancer 1 like; Leucine zipper protein down-regulated in cancer cells-like; Mammalian retrotransposon derived protein 6
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q6ICC9
-
Expression Region
1-239aa
-
AA Sequence
MGSSHHHHHHSSGLVPRGSHMGSHMVQPQTSKAESPALAASPNAQMDDVIDTLTSLRLTNSALRREASTLRAEKANLTNMLESVMAELTLLRTRARIPGALQITPPISSITSNGTRPMTTPPTSLPEPFSGDPGRLAGFLMQMDRFMIFQASRFPGEAERVAFLVSRLTGEAEKWAIPHMQPDSPLRNNYQGFLAELRRTYKSPLRHARRAQIRKTSASNRAVRERQMLCRQLASAGTGPCPVHPASNGTSPAPALPARARNL
-
Molecular Weight
28.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LDOC1L, or LDOC1-like protein, is a recently identified member of the LDOC1 family of proteins, which play crucial roles in various cellular processes, including cell signaling and immune responses. Research into LDOC1L is driven by its potential implications in human health, particularly in relation to cancer and inflammatory diseases. Recent studies have suggested that LDOC1L may be involved in modulating key signaling pathways, such as those governing apoptosis and cell proliferation. Its expression levels have been correlated with tumor progression in several types of cancers, indicating its possible utility as a biomarker or therapeutic target. Furthermore, LDOC1L's role in immune cell regulation highlights its significance in understanding autoimmune conditions. Investigating the biochemical properties and functions of LDOC1L through recombinant protein techniques can provide insights into its mechanisms of action and interactions with other cellular proteins. This research holds promise for developing novel treatment strategies that harness the capability of LDOC1L in modulating disease pathways. Understanding LDOC1L's structure and function could pave the way for innovative approaches in targeted therapies and personalized medicine.
